AMGEN INC (AMGN) Financials
Annual revenue, profitability and per-share results for AMGEN INC, as reported in SEC filings.
Revenue · FY2025
$36.75B
▲ 10.0%YoY
Net income · FY2025
$7.71B
▲ 88.5%YoY
Diluted EPS · FY2025
$14.23
▲ 88.2%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $36.75B | $7.71B | — | $14.23 | $8.10B | 24.7% | +10.0% |
| FY2024 | $33.42B | $4.09B | — | $7.56 | $10.39B | 21.7% | +18.6% |
| FY2023 | $28.19B | $6.72B | — | $12.49 | $7.36B | 28.0% | +7.1% |
| FY2022 | $26.32B | $6.55B | — | $12.11 | $8.79B | 36.3% | +1.3% |
Figures as reported in AMGEN INC's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a AMGN filing.
Get an email when AMGN files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.